AAME

Atlantic American Corp. Q1 2025 Filing Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2025. Atlantic American Corporation (AAME) operates as an insurance holding company with two primary segments: American Southern (property and casualty) and Bankers Fidelity (life and health). The company is classified as a non-accelerated filer and a smaller reporting company.

Key Financial Metrics

Note: Debt includes $4.0 million in revolving credit facility borrowings and $33.7 million in junior subordinated debentures.

Material Changes vs. Prior Period

• Profitability Turnaround: The company returned to profitability with $0.8 million in net income, reversing a $2.0 million loss in Q1 2024. This was driven by a $0.8 million unrealized gain on equity securities and improved underwriting results in the life and health segment.
• Revenue Growth: Total revenue increased 6.7% year-over-year. Net insurance premiums rose 5.3% to $46.9 million, primarily due to new sales in group accident/health and Medicare supplement lines.
• Segment Performance:
  • Bankers Fidelity (Life/Health): Achieved an underwriting profit of $0.5 million (Combined Ratio 98.2%) compared to a $2.8 million loss in Q1 2024. Loss ratio improved significantly to 60.6% from 71.7% due to lower Medicare supplement utilization.
  • American Southern (P&C): Reported an underwriting loss of $0.4 million (Combined Ratio 102.2%) compared to a $0.5 million profit in Q1 2024. The loss ratio increased to 79.6% due to higher losses in automobile physical damage and other lines.
• Investment Portfolio: Total investments increased to $232.5 million. Fixed maturities held $21.7 million in gross unrealized losses, primarily attributed to interest rate fluctuations rather than credit concerns. No allowance for credit losses was recorded.

Outlook, Risks, and Contingencies

• Internal Control Weakness: Management concluded that disclosure controls and procedures were not effective due to an unremediated material weakness in internal control over financial reporting. The weakness relates to the design of controls for reviewing insurance reserves and deferred acquisition costs in the life and health segment. Remediation is ongoing, with a new validation system expected to be fully operational by September 30, 2025.
• Liquidity: The company maintains a $10 million revolving credit facility with $6 million available. Statutory capital and surplus levels for subsidiaries remain adequate ($47.6 million for American Southern; $33.5 million for Bankers Fidelity).
• Forward-Looking Risks: Key risks include macroeconomic conditions, interest rate volatility affecting investment values, reinsurance availability and pricing, and the potential for unfavorable claim development or catastrophes.
• Dividends: The company declared a common stock dividend of $0.02 per share. Preferred stock dividends of $0.1 million were accrued.

Investor Verification Checklist

• Remediation Timeline: Verify the progress of the internal control remediation plan, specifically the implementation of the independent actuarial validation system scheduled for completion by Q3 2025.
• Loss Development: Monitor the stability of the improved loss ratio in the Bankers Fidelity segment to ensure the favorable development in Medicare supplement lines is sustainable.
• Investment Credit Quality: Review the composition of the $21.7 million in unrealized losses on fixed maturities to confirm they remain driven by interest rates and not deteriorating credit quality.
• Debt Covenants: Confirm continued compliance with the revolving credit facility covenants, specifically the minimum consolidated net worth requirement of $64.2 million.